An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCLLars Fabian Prinz(University of Cologne), Markus Chmielewski(University of Cologne)Cell Reports MedicineFebruary 1, 202410.1016/j.xcrm.2024.101421Cited by 13SaveCiteExport RISWatch citationsRelated PapersIL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression|Cancer Research|2011|541